WO2002070065A3 - Stimulation for delivery of molecular therapy - Google Patents

Stimulation for delivery of molecular therapy Download PDF

Info

Publication number
WO2002070065A3
WO2002070065A3 PCT/US2002/006800 US0206800W WO02070065A3 WO 2002070065 A3 WO2002070065 A3 WO 2002070065A3 US 0206800 W US0206800 W US 0206800W WO 02070065 A3 WO02070065 A3 WO 02070065A3
Authority
WO
WIPO (PCT)
Prior art keywords
stimulation
delivery
molecular therapy
provides
present
Prior art date
Application number
PCT/US2002/006800
Other languages
French (fr)
Other versions
WO2002070065A2 (en
Inventor
Maura G Donovan
Orhan Soykan
Curtis D Deno
Lawrence J Mulligan
Brian C A Fernandes
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/799,304 external-priority patent/US6810286B2/en
Application filed by Medtronic Inc filed Critical Medtronic Inc
Priority to EP02715051A priority Critical patent/EP1365835A2/en
Priority to JP2002569235A priority patent/JP2004523312A/en
Priority to CA002440514A priority patent/CA2440514A1/en
Publication of WO2002070065A2 publication Critical patent/WO2002070065A2/en
Publication of WO2002070065A3 publication Critical patent/WO2002070065A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention provides a novel stimulatory device for the controlled production of angiogenic growth factors. More specifically, the present invention provides a subthreshold pulse generator for the local production of vascular endothelial growth factor.
PCT/US2002/006800 2001-03-05 2002-02-28 Stimulation for delivery of molecular therapy WO2002070065A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02715051A EP1365835A2 (en) 2001-03-05 2002-02-28 Stimulation for delivery of molecular therapy
JP2002569235A JP2004523312A (en) 2001-03-05 2002-02-28 Stimulation for delivery of molecular therapy
CA002440514A CA2440514A1 (en) 2001-03-05 2002-02-28 Stimulation for delivery of molecular therapy

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27350101P 2001-03-05 2001-03-05
US60/273,501 2001-03-05
US09/799,304 2001-03-05
US09/799,304 US6810286B2 (en) 2000-03-06 2001-03-05 Stimulation for delivery of molecular therapy

Publications (2)

Publication Number Publication Date
WO2002070065A2 WO2002070065A2 (en) 2002-09-12
WO2002070065A3 true WO2002070065A3 (en) 2002-11-21

Family

ID=26956244

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/006800 WO2002070065A2 (en) 2001-03-05 2002-02-28 Stimulation for delivery of molecular therapy

Country Status (4)

Country Link
EP (1) EP1365835A2 (en)
JP (1) JP2004523312A (en)
CA (1) CA2440514A1 (en)
WO (1) WO2002070065A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003297592A1 (en) * 2002-11-30 2004-06-23 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
US20160361559A1 (en) 2007-10-12 2016-12-15 Berlin Heals Holding Ag Electromedical implantable or extracorporeally applicable device for the treatment or monitoring of organs, and method for therapeutic organ treatment
EP1868682A1 (en) 2005-04-06 2007-12-26 Friederike Scharmer Electromedical implantable or extracorporeally applicable device for the treatment or monitoring of organs, and method for therapeutic organ treatment
CN101405053B (en) * 2006-04-05 2012-08-29 槌屋橡胶株式会社 Biosome organization normalization method
US10940318B2 (en) * 2014-06-17 2021-03-09 Morton M. Mower Method and apparatus for electrical current therapy of biological tissue
EP3485801A1 (en) * 2017-11-19 2019-05-22 Indigo Diabetes N.V. Implantable integrated sensor device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999003533A1 (en) * 1997-07-16 1999-01-28 Impulse Dynamics (Israel) Ltd. Smooth muscle controller
WO1999036127A2 (en) * 1998-01-15 1999-07-22 Amethyst Technologies, Inc. Improved pulsed electromagnetic energy treatment apparatus and method
WO2000027466A1 (en) * 1998-11-12 2000-05-18 Emed Corporation Electrically mediated angiogenesis
WO2000053257A1 (en) * 1999-03-05 2000-09-14 Impulse Dynamics Nv Blood glucose level control
WO2000074773A1 (en) * 1999-06-04 2000-12-14 Impulse Dynamics N.V. Drug delivery device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601608A (en) * 1995-02-02 1997-02-11 Pacesetter, Inc. Methods and apparatus for applying charge-balanced antiarrhythmia shocks

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999003533A1 (en) * 1997-07-16 1999-01-28 Impulse Dynamics (Israel) Ltd. Smooth muscle controller
WO1999036127A2 (en) * 1998-01-15 1999-07-22 Amethyst Technologies, Inc. Improved pulsed electromagnetic energy treatment apparatus and method
WO2000027466A1 (en) * 1998-11-12 2000-05-18 Emed Corporation Electrically mediated angiogenesis
WO2000053257A1 (en) * 1999-03-05 2000-09-14 Impulse Dynamics Nv Blood glucose level control
WO2000074773A1 (en) * 1999-06-04 2000-12-14 Impulse Dynamics N.V. Drug delivery device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1365835A2 *

Also Published As

Publication number Publication date
CA2440514A1 (en) 2002-09-12
EP1365835A2 (en) 2003-12-03
JP2004523312A (en) 2004-08-05
WO2002070065A2 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
WO2004075736A3 (en) Aneurysm neck obstruction device
HK1050470A1 (en) Endovascular treatment for chronic venous insufficiency
AU2002252631A1 (en) Vascular endothelial growth factor 2
AU2002257241A1 (en) Vascular needle
AU2429401A (en) Implantable electro-acupuncture device
AU2001283518A1 (en) Method for controlling the pain from injections or minor surgical procedures andapparatus for use therewith
AU2002231024A1 (en) Heart valve holder that resists suture looping
AU2001601A (en) Implantable substrates for healing connective tissue
MXPA03008121A (en) 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi.
AU2001232209A1 (en) Non-thrombogenic implantable devices
AU2002357776A1 (en) Drug implant injection device
AU2001276689A1 (en) Novel remedies for cancer
AU2002256172A1 (en) Vascular endothelial growth factor 2
AU148080S (en) Spray pump head
WO2003039539A3 (en) Use of endothelin receptor antagonists in the treatment of tumour diseases
AU148079S (en) Spray pump head
WO2002070065A3 (en) Stimulation for delivery of molecular therapy
AU5497000A (en) Non-malignant disease treatment with ras antagonists
HK1042250A1 (en) Vegf angiogenic growth factors for treatment of peripheral neuropathy.
WO2003026689A8 (en) Autologous growth factor cocktail composition, method of production and use
AU1777301A (en) Production of ungulates, preferably bovines that produce human immunoglobulins
WO2003017819A3 (en) Defibrillators
ITGE20020050A1 (en) PROCESS FOR THE TREATMENT OF YARNS THROUGH NEEDLE.
WO2003092669A3 (en) Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac
AUPP863599A0 (en) Method of, and apparatus for, controlling the delivery of a medication

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2440514

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002569235

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002715051

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002715051

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642